1-9 of 9
Daniel J. Landsburg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series

Narendranath Epperla, Adam S. Zayac, Daniel J. Landsburg, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Habibe Kurt, Jose Sandoval-Sus, Mohammad Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L. Xu, Pallawi Torka, Suchitra Sundaram, Stephen D. Smith, Kikkeri N. Naresh, Yasmin Karimi, David A. Bond, Andrew M. Evens, Seema G. Naik, Manali Kamdar, Bradley M. Haverkos, Reem Karmali, Umar Farooq, Julie M. Vose, Paul Rubinstein, Amina Chaudhry, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5355–5364.
https://doi.org/10.1182/bloodadvances.2024013791
Published: 2024
Includes: Supplemental data
Journal Articles

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Clinical Trials & Observations
Rahul S. Bhansali, Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R. Hwang, N. Nora Bennani, Julio Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine M. Zain, Miguel Ruiz, Jonathan E. Brammer, Rishab Prakash, Swaminathan P. Iyer, Adam J. Olszewski, Ajay Major, Peter A. Riedell, Sonali M. Smith, Caroline Goldin, Bradley Haverkos, Bei Hu, Tony Z. Zhuang, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor R. Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M. Goodman, Gabrielle Hartman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3507–3518.
https://doi.org/10.1182/bloodadvances.2024012800
Published: 2024
Includes: Supplemental data
Journal Articles

Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines

Clinical Trials & Observations
Guido Ghilardi, Luca Paruzzo, Jakub Svoboda, Elise A. Chong, Alexander A. Shestov, Linhui Chen, Ivan J. Cohen, Giulia Gabrielli, Sunita D. Nasta, Patrizia Porazzi, Daniel J. Landsburg, James N. Gerson, Jordan Carter, Stefan K. Barta, Rebecca Yelton, Raymone Pajarillo, Vrutti Patel, Griffin White, Hatcher J. Ballard, Elizabeth Weber, Ellen Napier, Emeline R. Chong, Joseph A. Fraietta, Alfred L. Garfall, David L. Porter, Michael C. Milone, Roderick O’Connor, Stephen J. Schuster, Marco Ruella
Journal: Blood Advances
Blood Adv (2024) 8 (3): 653–666.
https://doi.org/10.1182/bloodadvances.2023011492
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma

James N. Gerson, Elizabeth Handorf, Diego Villa, Alina S. Gerrie, Parv Chapani, Shaoying Li, L. Jeffrey Medeiros, Michael Wang, Jonathon B. Cohen, Michael Churnetski, Brian T. Hill, Yazeed Sawalha, Francisco J. Hernandez-Ilizaliturri, Shalin Kothari, Julie M. Vose, Martin Bast, Timothy Fenske, Swapna Narayana Rao Gari, Kami J. Maddocks, David Bond, Veronika Bachanova, Bhaskar Kolla, Julio Chavez, Bijal Shah, Frederick Lansigan, Timothy Burns, Alexandra M. Donovan, Nina Wagner-Johnston, Marcus Messmer, Amitkumar Mehta, Jennifer K. Anderson, Nishitha Reddy, Alexandra E. Kovach, Daniel J. Landsburg, Martha Glenn, David J. Inwards, Kay Ristow, Reem Karmali, Jason B. Kaplan, Paolo F. Caimi, Saurabh Rajguru, Andrew Evens, Andreas Klein, Elvira Umyarova, Bhargavi Pulluri, Jennifer E. Amengual, Jennifer K. Lue, Catherine Diefenbach, Richard I. Fisher, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7393–7401.
https://doi.org/10.1182/bloodadvances.2023010757
Published: 2023
Includes: Supplemental data
Journal Articles

TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era

Daniel J. Landsburg, Jennifer JD Morrissette, Sunita D. Nasta, Stefan K. Barta, Stephen J. Schuster, Jakub Svoboda, Elise A. Chong, Adam Bagg
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7243–7253.
https://doi.org/10.1182/bloodadvances.2023011384
Published: 2023
Includes: Supplemental data
Journal Articles

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort

Jackson T. Bowers, Jacob Anna, Steven M. Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A. Spinner, Shuning Li, Marcus R. Messmer, Joseph Nguyen, Emily C. Ayers, Charlotte B. Wagner, Boyu Hu, Mengyang Di, Scott F. Huntington, Fateeha Furqan, Nirav N. Shah, Christina Chen, Hatcher J. Ballard, Mitchell E. Hughes, Elise A. Chong, Sunita D. Nasta, Stefan K. Barta, Daniel J. Landsburg, Jakub Svoboda
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6630–6638.
https://doi.org/10.1182/bloodadvances.2023010622
Published: 2023
Includes: Supplemental data
Journal Articles

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

Clinical Trials & Observations
Adam S. Zayac, Daniel J. Landsburg, Mitchell E. Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy K. Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, M. Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L. Xu, Pallawi Torka, Suchitra Sundaram, Stephen D. Smith, Kikkeri N. Naresh, Yasmin H. Karimi, Narendranath Epperla, David A. Bond, Umar Farooq, Mahak Saad, Andrew M. Evens, Karan Pandya, Seema G. Naik, Manali Kamdar, Bradley Haverkos, Reem Karmali, Timothy S. Oh, Julie M. Vose, Heather Nutsch, Paul G. Rubinstein, Amina Chaudhry, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6381–6394.
https://doi.org/10.1182/bloodadvances.2023009731
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

Clinical Trials & Observations
Pallawi Torka, Shalin K. Kothari, Suchitra Sundaram, Shaoying Li, L. Jeffrey Medeiros, Emily C. Ayers, Daniel J. Landsburg, David A. Bond, Kami J. Maddocks, Anshu Giri, Brian Hess, Luu Q. Pham, Ranjana Advani, Yang Liu, Stefan Klaus Barta, Julie M. Vose, Michael C. Churnetski, Jonathon B. Cohen, Madelyn Burkart, Reem Karmali, Joanna Zurko, Amitkumar Mehta, Adam J. Olszewski, Sarah Lee, Brian T. Hill, Timothy F. Burns, Frederick Lansigan, Emma Rabinovich, David Peace, Adrienne Groman, Kristopher Attwood, Francisco J. Hernandez-Ilizaliturri
Journal: Blood Advances
Blood Adv (2020) 4 (2): 253–262.
https://doi.org/10.1182/bloodadvances.2019000875
Published: 2020
Journal Articles

Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy

Clinical Trials & Observations
Daniel J. Landsburg, Mitchell E. Hughes, Alexa Koike, David Bond, Kami J. Maddocks, Ling Guo, Allison M. Winter, Brian T. Hill, Sarah L. Ondrejka, Eric D. Hsi, Sunita D. Nasta, Jakub Svoboda, Stephen J. Schuster, Agata M. Bogusz
Journal: Blood Advances
Blood Adv (2019) 3 (2): 132–135.
https://doi.org/10.1182/bloodadvances.2018026401
Published: 2019